Cargando…
CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)
BACKGROUND: Radiogenomics is an emerging tool with applications in screening for molecular biomarkers in diagnostic and prognostic assessment through the extraction of quantitative data from medical images (Shui et al., Front Oncol 2021). In this study, we aim to develop machine learning (ML) models...
Autores principales: | Ebrahimi, Hedyeh, Lu, Kun-Han, Castro, Daniela V, Mercier, Benjamin D, Dizman, Nazli, Barragan-Carrillo, Regina, Govindarajan, Ameish, Meza, Luis, Chawla, Neal S, Hsu, JoAnn, Chehrazi-Raffle, Alexander, Tripathi, Abhishek, Liu, Sandy, Dorff, Tanya B, Wah Wong, Chi, Pal, Sumanta K, Zengin, Zeynep B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445582/ http://dx.doi.org/10.1093/oncolo/oyad216.025 |
Ejemplares similares
-
The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
por: Castro, Daniela, et al.
Publicado: (2023) -
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
por: Meza, Luis, et al.
Publicado: (2023) -
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles
por: Govindarajan, Ameish, et al.
Publicado: (2023) -
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis
por: Dizman, Nazli, et al.
Publicado: (2020) -
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2023)